Certolizumab pegol na artrite reumatoide severa: evidência do mundo real em uma coorte Argentina: alcance de objetivos (t2t) em 3 meses e fatores preditivos.
October 2023
Hydroxychloroquine, and old acquaintance that gained strength in the pandemic.
As of December 2019, the COVID-19 epidemic represented one of the major therapeutic challenges faced to date, even more…
